Cargando…
Oxygen Sparing Effect of Bacteriotherapy in COVID-19
Background: We previously reported that severe COVID-19 patients had higher chances of survival and a reduced risk of developing respiratory failure when administered with the probiotic formulation SLAB51. This study aimed to investigate further bacteriotherapy mechanisms and how early they are acti...
Autores principales: | Ceccarelli, Giancarlo, Marazzato, Massimiliano, Celani, Luigi, Lombardi, Francesca, Piccirilli, Alessandra, Mancone, Massimo, Trinchieri, Vito, Pugliese, Francesco, Mastroianni, Claudio M., d’Ettorre, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401839/ https://www.ncbi.nlm.nih.gov/pubmed/34445055 http://dx.doi.org/10.3390/nu13082898 |
Ejemplares similares
-
Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021) -
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021) -
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
por: d'Ettorre, Gabriella, et al.
Publicado: (2020) -
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022) -
Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
por: Trinchieri, Vito, et al.
Publicado: (2022)